About Event
Discover the 4th LNP Immunogenicity & Toxicity Digital Summit
Returning as a one-day digital event, this year’s 4th LNP Immunogenicity & Toxicity Summit is committed to delivering the high-quality insights and global industry connections just for you, in a format that is accessible from the comfort of your home or office.
We’re excited to feature brand-new regulatory insights from the MHRA, alongside fresh case studies and strategic input from leading pharma including Genentech and Bayer. With an updated agenda packed with the latest approaches to overcoming immunogenicity and toxicity challenges, the summit continues to be the premier meeting point for advancing safer, more effective LNP-based therapies.
Unplug from your day-to-day tasks and replug into actionable insights with:
Regulatory First-Hand Advice
Hear directly from the MHRA on evolving safety and efficacy expectations, helping you design development strategies that anticipate approval requirements.
Big Pharma Perspectives
Learn how Bayer, AstraZeneca, and Genentech are tackling immunogenicity challenges in next-generation LNP-based vaccines and therapeutics.
AI-Driven Innovation
Discover how Mana.Bio is using machine learning to predict immune activation and design safer, smarter LNPs earlier in development.
Next-Generation Lipids
Gain practical lessons from Orna Therapeutics on advancing degradable and ligand-functionalized LNPs with integrated immunogenicity and toxicology assessment.
Translational Strategies
Uncover Pfizer’s and Sanofi’s approaches to bridging preclinical models with human data to reduce clinical surprises and accelerate safer therapies to patients.
Who Will You Meet?
Join senior scientists, Directors, CEOs and leaders in pharmacology, toxicology, immunology, delivery technologies, mRNA, vaccines, and LNP development, alongside CMC, regulatory, and analytical experts driving safer, more effective therapies.
Previous Attendees Include:
Don't Just Take Our Word For It:
"It was a well-organized conference around the 'hot' topics for LNP immunogenicity and toxicity. I liked the changes in the flow of the conference from talks and chats/discussions to workshops and brainstorming sessions – it allowed for the audience to digest and think about the material in creative ways, and also to interact in different ways. Also, there were plenty of networking opportunities."
"The topics of the summit that focused on the major challenges in the field and the selection of the experts who provide their assessment and solutions''
